ezogabine has been researched along with nitazoxanide in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (nitazoxanide) | Trials (nitazoxanide) | Recent Studies (post-2010) (nitazoxanide) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 573 | 85 | 352 |
| Protein | Taxonomy | ezogabine (IC50) | nitazoxanide (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.22 | |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 9.89 | |
| Anoctamin-1 | Homo sapiens (human) | 0.424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Guo, Y; Hu, X; Huang, H; Jin, Z; Li, Z; Liu, Z; Wang, K; Wang, Y; Zhang, L; Zhong, Y; Zong, X | 1 |
1 other study(ies) available for ezogabine and nitazoxanide
| Article | Year |
|---|---|
Optimization of 4-arylthiophene-3-carboxylic acid derivatives as inhibitors of ANO1: Lead optimization studies toward their analgesic efficacy for inflammatory pain.
Topics: Analgesics; Animals; Anoctamin-1; Carboxylic Acids; HEK293 Cells; Humans; Hyperalgesia; Mice; Neoplasm Proteins; Pain | 2022 |